COMPARISON OF HEMOSTASIS WITH 2 HIGH-FLUX HEMOCOMPATIBLE DIALYSIS MEMBRANES

被引:12
作者
LEITIENNE, P
TRZECIAK, MC
ADELEINE, P
VILLE, D
DECHAVANNE, M
TRAEGER, J
ZECH, P
机构
[1] HOP EDOUARD HERRIOT, INST PASTEUR, HEMOSTASE LAB, F-69374 LYON 08, FRANCE
[2] HOP LYON, INFORMAT MED LAB, LYON, FRANCE
[3] UNIV CLAUDE BERNARD LYON, HOP EDOUARD HERRIOT, CNRS, UA 1177, F-69437 LYON 03, FRANCE
关键词
DIALYSIS MEMBRANE; HEMOCOMPATIBILITY; HEMOSTASIS; HEPARIN;
D O I
10.1177/039139889101400405
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Eight adults with chronic renal failure were dialyzed using polyacrylonitrile (AN 69) or polysulfone (PS) membranes with a high (HHR) or low (LHR) continuous non-fractionated heparin regimen - a total of either 90 or 50 IU/kg body weight. With the HHR, for a mean anti-Xa (aXa) activity of around 0.40 IU/ml, no plasma activation of coagulation was observed; fibrinopeptide A (FPA) was in agreement with the residual blood volume (RBV) and the state of the bubble trap, especially with the PS membrane. With the LHR, for a mean aXa below 0.21 IU/ml, there was only moderate activation of coagulation. The PS membrane gave different results from the AN 69 membrane, RBV values on the HHR and aXa being lower on both the HHR and LHR, with FPA values being regularly lower on the LHR. The decrease in plasma beta-TG on the LHR was more marked with the PS than with the AN 69 membrane due to loss on dialysis or adsorption, as shown by the arterio-venous difference. The increase in plasma PF4 was related to the effect of heparin. However, there was no platelet activation. On the LHR, platelet count and intraplatelet beta-TG and PF4 levels remained very stable. The two high-flux membranes were very hemocompatible and require only low doses of heparin, but the dialyzer with AN 69 membrane need its geometry improving.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 23 条
[1]  
Andrassy K, 1987, Contrib Nephrol, V59, P26
[2]  
Bosch T, 1987, Contrib Nephrol, V59, P90
[3]  
BRYNGER H, 1980, 1979 P EUR DIAL TRAN, V17, P4
[4]   THE INVIVO RELEASE OF HUMAN-PLATELET FACTOR-4 BY HEPARIN [J].
DAWES, J ;
PUMPHREY, CW ;
MCLAREN, KM ;
PROWSE, CV ;
PEPPER, DS .
THROMBOSIS RESEARCH, 1982, 27 (01) :65-76
[5]   BETA-THROMBOGLOBULIN IS ELEVATED IN RENAL-FAILURE WITHOUT THROMBOSIS [J].
DEPPERMANN, D ;
ANDRASSY, K ;
SEELIG, H ;
RITZ, E ;
POST, D .
THROMBOSIS RESEARCH, 1980, 17 (1-2) :63-69
[6]  
GUNNARSSON B, 1981, CLIN NEPHROL, V15, P135
[7]  
HENDERSON L W, 1987, Blood Purification, V5, P100, DOI 10.1159/000169459
[8]  
Hildebrand U, 1985, Contrib Nephrol, V46, P92
[9]  
IRELAND H, 1984, J LAB CLIN MED, V103, P643
[10]  
Lysaght M J, 1988, Contrib Nephrol, V61, P1